Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: October 4, 2022

Cipla Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for CIPLA LTD, and what generic and branded alternatives to CIPLA LTD drugs are available?

CIPLA LTD has ten approved drugs.

There are eight tentative approvals on CIPLA LTD drugs.

Summary for Cipla Ltd

US Patents:	0
Tradenames:	9
Ingredients:	9
NDAs:	10
Drug Master File Entries:	217
PTAB Cases with Cipla Ltd as petitioner:	See PTAB cases with Cipla Ltd as petitioner

Drugs and US Patents for Cipla Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipla Ltd	CARBOPLATIN	carboplatin	INJECTABLE;INJECTION	077383-002	Jan 27, 2006		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Cipla Ltd	EPIRUBICIN HYDROCHLORIDE	epirubicin hydrochloride	INJECTABLE;INJECTION	065361-002	Oct 22, 2007	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Cipla Ltd	ZIDOVUDINE	zidovudine	CAPSULE;ORAL	078349-001	May 23, 2007	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Cipla Ltd	CETIRIZINE HYDROCHLORIDE ALLERGY	cetirizine hydrochloride	TABLET;ORAL	077318-002	Jul 25, 2013		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Dow

Medtronic

Boehringer Ingelheim

Express Scripts

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.